News

Pharming Group Set to Engage Investors at Major Conference

Pharming Group Set to Engage Investors at Major Conference

Pharming Group's Upcoming Participation in an Investor Conference

Pharming Group N.V. recently announced its engagement in a significant investor conference scheduled for March. The excitement surrounding this engagement reflects the company's ongoing commitment to connect with investors and discuss their innovative approaches in the biopharmaceutical sector.

Details of the Investor Conference

The highlight of Pharming's participation will be at the 37th Annual Roth Conference, which is set to take place in Dana Point, CA. This prestigious event occurs from March 16 to March 18, 2025. Notably, Anurag Relan, Chief Medical Officer, and Michael Levitan, Vice President of Investor Relations and Corporate Communications, will lead the conversation during a fireside chat. This interactive session is slated for March 17 at 1:30 PM PT/9:30 PM CET, providing a valuable opportunity for attendees to learn more about Pharming's initiatives.

Connecting with Pharming's Management Team

Investors interested in a deeper dialogue with the management team can arrange one-on-one meetings during the conference. For additional details about the conference or to schedule a personal meeting, attendees are encouraged to reach out to Pharming's Investor Relations team directly at investor@pharming.com.

About Pharming Group N.V.

Pharming Group N.V. (NASDAQ: PHAR) is a leading global biopharmaceutical company committed to enriching the lives of patients suffering from rare and severe diseases. The company's mission revolves around the development and commercialization of a unique portfolio of protein replacement therapies and precision medicines. The extensive reach of Pharming's operations spans over 30 markets, including regions in North America, Europe, the Middle East, Africa, and Asia-Pacific.

Innovative Therapies by Pharming

The innovative therapies that Pharming is bringing to the forefront promise transformative effects for patients with complex health issues. By harnessing advanced protein replacement technology, Pharming aims to provide effective solutions for conditions that currently have limited treatment options. The development pipelines are robust, showcasing their dedication to research and development in the biopharmaceutical landscape.

Company Headquarters and Global Reach

Headquartered in Leiden, the Netherlands, Pharming Group employs a diverse workforce dedicated to serving patients around the globe. The company’s emphasis on biopharmaceutical research not only represents their commitment to patient care but also highlights their role in advancing the treatment paradigms in rare diseases.

Contact Information for Inquiries

For further inquiries regarding Pharming, interested parties can contact Michael Levitan, VP of Investor Relations and Corporate Communications, at +1 (908) 705 1696 or through investor@pharming.com. Furthermore, for general public relations, FTI Consulting in London can also be contacted at +44 203 727 1000.

Frequently Asked Questions

What is the purpose of the investor conference Phar is attending?

The investor conference is an opportunity for Pharming Group to engage with investors, discuss their latest innovations, and foster relationships within the biopharmaceutical community.

Who will represent Pharming at the conference?

Anurag Relan, Chief Medical Officer, and Michael Levitan, VP of Investor Relations and Corporate Communications, will represent Pharming at the conference.

When is the conference happening?

The 37th Annual Roth Conference occurs from March 16-18, 2025, with Pharming's presentation scheduled for March 17.

How can investors meet with Pharming's management?

Investors can arrange one-on-one meetings by contacting Pharming's Investor Relations team via email at investor@pharming.com.

What is Pharming's primary focus?

Pharming focuses on developing innovative protein replacement therapies and precision medicines for patients suffering from rare and severe diseases.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 0

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 128

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
Jeff Stern Turns Travel Photography Into Full Attention

Updated Category News Views 57

A cancelled photography conference in March 2020 sent Jeff Stern toward the American Southwest, and that detour eventually became A Change of Scenery. Frankly, that origin has more grit than the usual polished creative-origin tale. While much of the world had stopped moving, Stern went alone, stood at White Pocket beneath a cobalt sky, and began reconsidering what he...

Continue Reading
Movement Elevates a Longtime Insider as Its New CEO

Updated Category News Views 81

Chalk dust rarely makes headlines, yet this is the sort of leadership change that can decide whether a consumer brand keeps its footing. Movement Climbing, Yoga and Fitness named Ryan Sewell chief executive officer effective November 18, 2026, with Anne-Worley Moelter moving into the chairperson role. It is a conspicuously internal handoff: Sewell started at the Boulder...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 158

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 30

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 82

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
NKT’s Q3 Margin Holds Up as Capacity Spending Bites

Updated Category News Views 119

Steel, copper and giant cable drums do not make for a pretty quarterly story, but NKT’s numbers have a sturdier backbone than the headline revenue dip suggests. The company delivered EUR 111 million of operational EBITDA in Q3 2026, down from EUR 119 million a year earlier, while its margin at standard metal prices edged up to 16.6% from 16.4%. That is not fireworks. It...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 18

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading

Top 5 Most Recently Viewed Articles

Immutable Expands Web3 Gaming Influence in Major Conference

Updated Category News Views 257

Immutable's Growing Presence at GDC 2025 Immutable is affirmatively stepping into the spotlight at the upcoming Game Developers Conference (GDC) 2025, a pivotal event that congregates the brightest minds of the gaming industry. With collaborations alongside notable partners such as RavenQuest, Polygon Labs, Sequence, and MetaGravity, Immutable is ready to showcase its...

Continue Reading
Rathbones Group's Influence on Empiric Student Property Plc

Updated Category News Views 239

Understanding Public Opening Position Disclosures Public opening position disclosures are essential for maintaining transparency in financial markets. This process is especially important for stakeholders interested in relevant securities, particularly when holdings exceed 1%. Disclosures must provide critical information on who owns shares and any short positions related...

Continue Reading
Rapid Nexus Achieves Historic Milestone in Wound Care Technology

Updated Category News Views 389

Rapid Nexus Receives FDA Clearance for Hemastyl Gel The FDA 510(k) clearance for its Hemastyl gel device marks the first technology that has treated the tissue surrounding chronic wounds and prevented numerous amputations. On a significant day in the realm of wound care, Rapid Nexus, a pioneering California-based med-tech company, has announced the receipt of FDA 510(k)...

Continue Reading
Grainger Approves Substantial Dividend to Shareholders

Updated Category News Views 131

Grainger's Commitment to Shareholders Through Dividends W.W. Grainger, Inc. (NYSE: GWW) has recently taken significant steps to reward its investors. The board of directors has officially approved a cash dividend of $2.26 per share. This strong move by Grainger underscores its commitment to providing long-term value to its shareholders. Details of the Dividend...

Continue Reading
Grupo Aeroportuario del Pacífico Secures New Credit Line Deal

Updated Category News Views 236

Grupo Aeroportuario del Pacífico Unveils Expanded Credit Line Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (PAC), a prominent player in the Mexican aviation sector, has recently announced a significant refinancing of its credit arrangements. The company has successfully secured a USD $40 million credit line from Banco Nacional de México, S.A. (Banamex). This...

Continue Reading